18Sep
Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices
On September 4, 2019 the Department of Justice (DOJ) announced a $15.4 million settlement with pharmaceutical company Mallinckrodt ARD LLC (Mallinckrodt) to resolve alleged violations of the Anti-Kickback Statute (AKS) in two whistleblower suits...
By:
Robinson+Cole Health Law Diagnosis
Related
Statements to Individuals- The Internal Revenue Service (“IRS”) has extended the deadline for 2019...
Read More >
Client issues often arrive like schools of fish – rapidly and in huge numbers. Sometimes this is th...
Read More >
WHAT HAPPENED: • On September 4, 2019, the US Department of Justice’s Antitrust Division (DOJ) su...
Read More >
On December 6, 2019, the New Jersey Appellate Division in V. L. v. Hunterdon Healthcare et. al., rev...
Read More >
In this episode of The Proskauer Brief, partners Harris Mufson and Evandro Gigante discuss considera...
Read More >
As detailed in our June 2019 alert, the New York State legislature passed sweeping legislation desig...
Read More >